News Archives - Primmune

Primmune Therapeutics Announces Close of Series A Financing

Jan 12, 2021 | News

SAN DIEGO, January 12, 2021 – Today, Primmune Therapeutics announced the close of its Series A financing round with the addition of $4.0 million from Bioqube Ventures, a European life sciences venture capital firm. This brings the total of the Series A financing raise...

Primmune Pays its Paycheck Protection Program Loan in Full

Nov 4, 2020 | News

Primmune received a Paycheck Protection Program (“PPP”) loan from Silicon Valley Bank on April 30, 2020. On November 4, 2020, Primmune paid its PPP loan in full.

Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases

Mar 2, 2020 | News, Press Releases

SAN DIEGO, March 2, 2020 – Primmune Therapeutics today announced that it has raised $7 million in seed financing to support the development of novel orally-administered, small molecule toll-like receptor 7 (TLR7) agonists for long-term systemic activation of innate...